In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sequella Inc.

Latest From Sequella Inc.

Tuberculosis: An Old Killer Proving Difficult To Best

With the announcement that tuberculosis surpassed HIV/AIDS in attributable deaths from infectious diseases worldwide, there has been a renewed interest in the development of new treatments and regimens for dealing with what is now the world’s number one infectious disease killer.

Research & Development Infectious Diseases

World TB Day 2015: new drugs, new methods, new guidance

World TB Day, which takes place each year on 24 March, is the event at which bodies like the World Health Organization and the Stop TB Partnership report on progress with efforts to fight TB and exhort governments, civil society groups, healthcare providers and others to speed up those efforts.

Infectious Diseases Russian Federation

Sequella CEO Carol Nacy On Partnering With Pfizer To Solve Multidrug-resistant TB

New drugs in development could help solve a looming global multidrug-resistant TB epidemic and anchor a new treatment regimen.

BioPharmaceutical Asia Pacific

Deals Shaping The Medical Industry, September 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Sequella Inc.
  • Senior Management
  • Carol A Nacy, PhD, Chmn. & CEO
    Marty Zug, CFO
    Alan S Klein, EVP, Corp. Dev.
    Leo Einck, PhD, CSO
    Gary Horwith, MD, CMO
  • Contact Info
  • Sequella Inc.
    Phone: (301) 762-7776
    9610 Medical Center Dr., Ste. 200
    Rockville, MD 20850